Table 3 Baseline and last available LDCT screening findings of participants who died of pancreatic cancer within 24 months of their last LDCT screening: original reports versus re-review. The original reports did not document any pancreatic findings, whereas the re-review by experienced radiologists identified undocumented pancreatic findings in 42% of last available LDCT scans and 29% of baseline LDCT scans. This comparison highlights the importance of thoroughly examining the pancreas, even if it is not the primary focus of lung cancer screening.

From: GI cancer mortality in participants in low dose CT screening for lung cancer with a focus on pancreatic cancer

 

Original report

n = 14 (%)

Re-review

n = 14 (%)

p-value

Pancreatic lesion on the baseline LDCT

Calcification(s)

Atrophy/Fatty infiltration

0

0

1 (14.3)

4 (28.6)

1

0.09

Pancreatic lesion on the last LDCT

Calcification(s)

Atrophy/Fatty infiltration

0

0

3 (21.4)

4 (28.6)

0.22

0.09